HIGHLIGHTS
- What: The abundance of microorganisms that inhabit the human body and their critical roles in human health and disease present unlimited potential for microbiome-engineered therapeutics.
- Who: Jacqueline L. Boyajian and collaborators from the Health Sciences, McGill University, Montreal H A , Quebec, Canada have published the Article: Probiotics, prebiotics, synbiotics and other microbiome-based innovative therapeutics to mitigate obesity and enhance longevity via the gut-brain axis, in the Journal: (JOURNAL)
- How: This review discusses the interrelationship between obesity and aging with a particular emphasis on the gut microbiome and presents biotics as . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.